Global leader in clinical diagnostics selects clinivation to advance multinational market access initiatives.
NATICK, MA – March 22, 2010 – Clinivation, Inc. is pleased to announce today that Beckman Coulter has selected clinivation to advance certain multinational market access initiatives.
Ever-proliferating and changing global regulations generate complex challenges of execution in global market clearance operations.
Clinivation’s experienced Technology-Enabled CRO Services team understands how to approach and overcome complex development, quality, regulatory, and market access hurdles.
Unlike traditional consulting, Technology-Enabled CRO Services can employ domain-specific information technology to achieve a high operational tempo and an operational fluidity that advances to milestones and deliverables with quality and efficiency.
Quotes & Commentary:
“We look forward working with the Beckman Coulter teams around the world and in the U.S., and advancing the multinational market access initiatives,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
Supporting Resources:
For more information on the clinivation’s Technology-Enabled CRO Services, please visit the clinivation CRO Services homepage
For more information on the clinivation Enterprise Solution for Global Market Clearance Management, please visit the clinivation Global homepage.
For more information on the clinivation Enterprise Solution for On-Demand Global Regulatory Intelligence, please visit the clinivation WorldView homepage.
About Beckman Coulter:
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes.
Spanning the biomedical testing continuum-from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing-Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world.
